Online inquiry

IVTScrip™ mRNA-Human ALAS2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK19588MR)

This product GTTS-WK19588MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ALAS2 protein. This product can be used in Erythroblast-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_000032.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 212
UniProt ID P22557
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ALAS2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK19588MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK14161MR IVTScrip™ mRNA-Human ABHD12B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ABHD12B
GTTS-WK16579MR IVTScrip™ mRNA-Human AKR7A2, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AKR7A2
GTTS-WK18426MR IVTScrip™ mRNA-Human ALKBH5, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ALKBH5
GTTS-WK17504MR IVTScrip™ mRNA-Human ALDH6A1, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ALDH6A1
GTTS-WK19930MR IVTScrip™ mRNA-Human ALOX12P2, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ALOX12P2
GTTS-WK10613MR IVTScrip™ mRNA-Human ACAT1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ACAT1
GTTS-WK2684MR IVTScrip™ mRNA-Human CHST8, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA CHST8
GTTS-WK2015MR IVTScrip™ mRNA-Human PKC-alpha, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA PKC-alpha
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →